Skip to main content

Utah Medical Products Inc

UTMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000706698

No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Utah Medical Products Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of UTMD: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders7882+4
Shares2.54M2.55M+10.7K (+0.4%)
Value$216.3M$256.0M+$39.7M (+18.3%)

New holders (7)

Institutions that held Utah Medical Products Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to UTMD in Q4 2022
InstitutionSharesValue% of portfolio
Legato Capital Management LLC2,367$238.0K0.05%
Penn Mutual Asset Management, LLC2,300$231.2K0.26%
D. E. Shaw & Co., Inc.2,088$209.9K0.00%
UBS Group AG1,590$159.8K0.00%
GWM Advisors LLC612$53.1K0.00%
Belpointe Asset Management LLC400$40.2K0.00%
Rockefeller Capital Management L.P.131$13.0K0.00%

Sold out (3)

Institutions that held Utah Medical Products Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of UTMD in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Brandes Investment Partners, LP7,858$670.0K
Credit Suisse AG17$1.00K
Bourgeon Capital Management LLC3$0